betrixaban

Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod
Xconomy
Sat, 06/24/17 - 09:20 am
Portola Pharmaceuticals
blood clots
FDA
Bevyxxa
betrixaban
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
Can 'Santa Claus' Rally Continue For These 3 Small Biotechs?
Seeking Alpha
Tue, 12/27/16 - 10:15 am
biotech
Portola
betrixaban
Synergy Pharmaceuticals
plecanatide
Progenics
prostate cancer
Portola's Lesson For 'Innovative' Clinical Trial Designers
Forbes
Thu, 03/31/16 - 10:33 am
Portola Pharmaceuticals
clinical trials
betrixaban
Merck returns $50M anti-clotting drug betrixaban to Portola
bizjournals.com
Thu, 03/24/11 - 03:14 pm
Merck
betrixaban
Portola Pharmaceuticals
anti-clotting
How To Tell Merck's Two Blood Thinners Apart
Forbes
Fri, 05/14/10 - 08:23 am
blood thinners
Merck
Vorapaxar
betrixaban
Portola, Merck anticoagulant shows strong response
Bizjournals.com
Mon, 03/15/10 - 04:18 pm
anticoagulants
Portola Pharmaceuticals
Merck
betrixaban
Merck Enters Licensing Agreement With Portola for Stroke Drug
Bloomberg
Thu, 07/9/09 - 08:32 am
Merck
stroke
licensing
Portola Pharmaceuticals
betrixaban